In this regard, previous reports showed that the loss of p53-mediated genomic surveillance and over-expression of c-Myc result in the suppression of DNA repair and enhancement of the mutation rate in cancer cells [18], and once the tumors become established, c-Myc is a key gene player in alternative macrophage activation and pro-tumorigenic gene expression [2]. This evidence concerns the gene TP53 and cancer.